🧠 Neuralink: Key Data & Projections
Comprehensive Analysis for Investors, Engineers & Visionaries
⚡ BCI Technology Comparison: Neuralink vs. Competition
| Metric | Neuralink | Synchron | Blackrock | Paradromics | Precision |
|---|---|---|---|---|---|
| Electrode Count | 1,024+ | 16 | 100 | 10,000+ (dev) | 1,024 |
| Wireless | ✓ Yes | ✓ Yes | ✗ No | Planned | ✓ Yes |
| Invasiveness | Medium | Low | High | High | Low |
| Human Trials | ✓ 2 patients | ✓ 4+ patients | ✓ 50+ patients | ✗ Pre-trial | ✓ Temporary |
| FDA Status | Approved (PRIME) | Approved | Cleared | Pre-trial | Early trials |
| Surgical Robot | ✓ R1 (automated) | ✗ Catheter | ✗ Manual | ✗ Manual | ✗ Manual |
| Valuation | $8-10B | $1B+ | Private | Private | Private |
| Funding | $680M+ | $145M | N/A | $100M+ | $53M |
📊 Patient Performance Metrics
⚙️ N1 Implant Specifications
💰 Total Addressable Market (TAM) Analysis
Medical Applications (Conservative)
Augmentation Market (Speculative - 2035+)
📈 Revenue Projections (2025-2040)
🗓️ Neuralink Development Timeline
Founded
Musk invests $100M, recruits 8 co-founders from neuroscience and engineering
Animal Testing Begins
Rats, pigs demonstrate basic functionality. Thread technology developed.
Gertrude the Pig Demo
First public demonstration of wireless N1 implant recording neural activity
Pager Plays Pong
Monkey controls video game with mind via 1,000+ electrode array
FDA Approval (PRIME Study)
Breakthrough Device designation granted for human trials in paralysis patients
First Human Implant
Noland Arbaugh receives N1 implant, begins cursor control and typing
Second Patient
Alex receives improved implant with resolved thread anchoring
Blindsight FDA Approval
Breakthrough Device designation for vision restoration system
PRIME Study Completion
Target: 10 patients implanted, 12-month safety data, first Blindsight patient
Clinical Expansion
50-100 patients, multiple indications, manufacturing scaled to 1,000+ devices/year
FDA Approval & Commercial Launch
PMA submission, approval for quadriplegia indication, limited commercial sales begin
Medical Market Growth
10,000+ patients, multiple approved indications, $500M-2B revenue
Augmentation Era Begins
First healthy-person trials, cognitive enhancement demonstrations, regulatory debates intensify